NO20056207L - Sammensetning for vaksinering av hunder - Google Patents
Sammensetning for vaksinering av hunderInfo
- Publication number
- NO20056207L NO20056207L NO20056207A NO20056207A NO20056207L NO 20056207 L NO20056207 L NO 20056207L NO 20056207 A NO20056207 A NO 20056207A NO 20056207 A NO20056207 A NO 20056207A NO 20056207 L NO20056207 L NO 20056207L
- Authority
- NO
- Norway
- Prior art keywords
- cynos
- dogs
- attenuated
- dog
- raising
- Prior art date
Links
- 241000282472 Canis lupus familiaris Species 0.000 title abstract 4
- 238000002255 vaccination Methods 0.000 title 1
- 241000694560 Mycoplasma cynos Species 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 241000282465 Canis Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0315323.6A GB0315323D0 (en) | 2003-07-01 | 2003-07-01 | Vaccine composition |
| PCT/GB2004/002865 WO2005002618A1 (en) | 2003-07-01 | 2004-07-01 | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20056207L true NO20056207L (no) | 2006-01-31 |
Family
ID=27676393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20056207A NO20056207L (no) | 2003-07-01 | 2005-12-27 | Sammensetning for vaksinering av hunder |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8329194B2 (de) |
| EP (2) | EP2050463B1 (de) |
| JP (1) | JP5698890B2 (de) |
| KR (1) | KR20060106809A (de) |
| CN (1) | CN1845754A (de) |
| AT (1) | ATE442857T1 (de) |
| AU (1) | AU2004253344B2 (de) |
| BR (1) | BRPI0412194A (de) |
| CA (1) | CA2530797C (de) |
| DE (1) | DE602004023196D1 (de) |
| DK (1) | DK2050463T3 (de) |
| ES (2) | ES2356396T3 (de) |
| GB (1) | GB0315323D0 (de) |
| MX (1) | MXPA06000278A (de) |
| NO (1) | NO20056207L (de) |
| NZ (1) | NZ544453A (de) |
| PT (1) | PT2050463E (de) |
| RU (1) | RU2006102863A (de) |
| WO (1) | WO2005002618A1 (de) |
| ZA (1) | ZA200600918B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| CN100388952C (zh) * | 2006-04-25 | 2008-05-21 | 范红结 | 一种链球菌重组亚单位疫苗及其制备方法 |
| UA99719C2 (ru) * | 2006-11-03 | 2012-09-25 | Шеринг-Плау Лтд. | Вакцина для собак против болезни лайма |
| WO2011112593A1 (en) * | 2010-03-10 | 2011-09-15 | Intervet International B.V. | Method for protecting against disease caused by secondary pathogens |
| PL2670432T3 (pl) | 2011-02-04 | 2021-10-11 | Zoetis Services Llc | Kompozycje immunogenne Bordetella bronchiseptica |
| CA2826058C (en) | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
| EP2854847B1 (de) | 2012-05-31 | 2019-08-07 | Zoetis Services LLC | Impfung mit caninem respiratorischem coronavirus zum schutz vor infektionen von b. bronchiseptica |
| CN111499702B (zh) * | 2020-05-07 | 2021-04-06 | 山东畜牧兽医职业学院 | 一种马链球菌兽疫亚种的检测试剂盒及检测方法 |
| MX2023003961A (es) * | 2020-10-08 | 2023-06-02 | Controlpoint Inc | Metodos y aparatos para detectar infecciones respiratorias. |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
| US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| GB8426468D0 (en) | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| GB8517895D0 (en) | 1985-07-16 | 1985-08-21 | Technology Licence Co Ltd | Monoclonal antibodies |
| ATE71303T1 (de) | 1986-01-14 | 1992-01-15 | Nederlanden Staat | Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung. |
| US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
| US4944942A (en) * | 1987-08-27 | 1990-07-31 | Mobay Corporation | Intranasal vaccination of horses with inactivated microorganisms or antigenic material |
| US4944972A (en) * | 1987-12-31 | 1990-07-31 | American National Can Company | Coextrusion apparatus, methods, and related films and packages |
| US5672350A (en) | 1989-08-22 | 1997-09-30 | Veterinary Infectious Disease Organization | Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines |
| GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
| US5178860A (en) * | 1989-09-01 | 1993-01-12 | Coopers Animal Health Limited | Adjuvant complexes and vaccine made therefrom |
| US5583014A (en) * | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
| US6057436A (en) | 1990-11-14 | 2000-05-02 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| NZ240558A (en) | 1990-11-14 | 1994-11-25 | Smithkline Beecham Corp | Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease |
| US6372224B1 (en) | 1990-11-14 | 2002-04-16 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| ES2213743T3 (es) | 1991-04-25 | 2004-09-01 | Akzo Nobel N.V. | Vacuna de subunidad de coronavirus canino. |
| DE4134297A1 (de) * | 1991-10-17 | 1993-04-22 | Behringwerke Ag | Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung |
| ES2182827T3 (es) | 1992-05-08 | 2003-03-16 | Pfizer | Gen del virus corona canino y usos del mismo. |
| US5750112A (en) | 1993-02-26 | 1998-05-12 | Solvay Animal Health, Inc. | Canine coronavirus vaccine from feline enteric coronavirus |
| CA2183684C (en) * | 1994-02-18 | 2008-07-15 | Richard D. Hansen | Inoculation of animals with dried, pelleted biological materials |
| WO1996041874A1 (en) | 1995-06-12 | 1996-12-27 | Kansas State University Research Foundation | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
| WO1998016643A1 (en) | 1996-10-11 | 1998-04-23 | Human Genome Sciences, Inc. | Brain-associated inhibitor of tissue-type plasminogen activator |
| US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| US6682745B1 (en) * | 1998-07-28 | 2004-01-27 | Christiaan Antonius Arnoldus Jacobs | Use of bacterium for manufacture of a vaccine |
| WO1999025838A1 (en) | 1997-11-14 | 1999-05-27 | University Of Georgia Research Foundation, Inc. | Compositions and methods to prevent turkey enteritis |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| EP1023903B1 (de) | 1999-01-26 | 2004-01-14 | Akzo Nobel N.V. | Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes |
| US20010048927A1 (en) * | 2000-02-01 | 2001-12-06 | Richard Stephens | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
| WO2003018051A1 (en) * | 2001-08-27 | 2003-03-06 | Vic Jira | Anti-fungal composition |
| GB0217434D0 (en) * | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
| US8404245B2 (en) | 2002-10-11 | 2013-03-26 | Intervacc Ab | Immunization of non-human mammals against Streptococcus equi |
| US7793433B2 (en) * | 2006-07-14 | 2010-09-14 | Footbalance System Oy | Individually formed footwear and a related method |
-
2003
- 2003-07-01 GB GBGB0315323.6A patent/GB0315323D0/en not_active Ceased
-
2004
- 2004-07-01 ES ES04743211T patent/ES2356396T3/es not_active Expired - Lifetime
- 2004-07-01 MX MXPA06000278A patent/MXPA06000278A/es unknown
- 2004-07-01 ES ES08075914T patent/ES2432175T3/es not_active Expired - Lifetime
- 2004-07-01 NZ NZ544453A patent/NZ544453A/xx not_active IP Right Cessation
- 2004-07-01 EP EP08075914.5A patent/EP2050463B1/de not_active Expired - Lifetime
- 2004-07-01 WO PCT/GB2004/002865 patent/WO2005002618A1/en not_active Ceased
- 2004-07-01 DE DE602004023196T patent/DE602004023196D1/de not_active Expired - Lifetime
- 2004-07-01 EP EP04743211A patent/EP1638599B1/de not_active Expired - Lifetime
- 2004-07-01 AU AU2004253344A patent/AU2004253344B2/en not_active Ceased
- 2004-07-01 US US10/563,199 patent/US8329194B2/en not_active Expired - Fee Related
- 2004-07-01 RU RU2006102863/15A patent/RU2006102863A/ru not_active Application Discontinuation
- 2004-07-01 BR BRPI0412194-5A patent/BRPI0412194A/pt not_active Application Discontinuation
- 2004-07-01 CN CNA2004800250016A patent/CN1845754A/zh active Pending
- 2004-07-01 CA CA2530797A patent/CA2530797C/en not_active Expired - Fee Related
- 2004-07-01 PT PT80759145T patent/PT2050463E/pt unknown
- 2004-07-01 AT AT04743211T patent/ATE442857T1/de not_active IP Right Cessation
- 2004-07-01 DK DK08075914.5T patent/DK2050463T3/da active
- 2004-07-01 KR KR1020067000080A patent/KR20060106809A/ko not_active Withdrawn
- 2004-07-01 JP JP2006518335A patent/JP5698890B2/ja not_active Expired - Fee Related
-
2005
- 2005-12-27 NO NO20056207A patent/NO20056207L/no not_active Application Discontinuation
-
2006
- 2006-01-31 ZA ZA200600918A patent/ZA200600918B/en unknown
-
2007
- 2007-09-04 US US11/849,931 patent/US20080220018A1/en not_active Abandoned
-
2010
- 2010-06-15 US US12/816,214 patent/US20110059128A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK2050463T3 (da) | 2013-09-02 |
| US20070098739A1 (en) | 2007-05-03 |
| ES2432175T3 (es) | 2013-12-02 |
| US20110059128A1 (en) | 2011-03-10 |
| ES2356396T3 (es) | 2011-04-07 |
| EP2050463A3 (de) | 2010-01-20 |
| WO2005002618A1 (en) | 2005-01-13 |
| ATE442857T1 (de) | 2009-10-15 |
| US20080220018A1 (en) | 2008-09-11 |
| PT2050463E (pt) | 2013-10-29 |
| ZA200600918B (en) | 2007-07-25 |
| NZ544453A (en) | 2009-04-30 |
| GB0315323D0 (en) | 2003-08-06 |
| CA2530797C (en) | 2014-08-26 |
| US8329194B2 (en) | 2012-12-11 |
| MXPA06000278A (es) | 2006-04-07 |
| RU2006102863A (ru) | 2006-09-10 |
| CA2530797A1 (en) | 2005-01-13 |
| DE602004023196D1 (de) | 2009-10-29 |
| BRPI0412194A (pt) | 2006-08-22 |
| JP2007526884A (ja) | 2007-09-20 |
| AU2004253344A1 (en) | 2005-01-13 |
| KR20060106809A (ko) | 2006-10-12 |
| EP1638599A1 (de) | 2006-03-29 |
| CN1845754A (zh) | 2006-10-11 |
| EP2050463B1 (de) | 2013-08-21 |
| AU2004253344B2 (en) | 2010-04-29 |
| EP1638599B1 (de) | 2009-09-16 |
| JP5698890B2 (ja) | 2015-04-08 |
| EP2050463A2 (de) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120015T1 (el) | Μεθοδοι χορηγησης εμβολιων | |
| WO2008073891A3 (en) | Salmonella vaccine in poultry | |
| NO20056207L (no) | Sammensetning for vaksinering av hunder | |
| ATE461710T1 (de) | Nipah-virus-impfstoffe | |
| PA8549801A1 (es) | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales | |
| Sautto et al. | Next generation vaccines for infectious diseases | |
| CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
| Scheerlinck et al. | Particulate delivery systems for animal vaccines | |
| WO2007140244A3 (en) | Vaccination of young animals against lawsonia intracellularis infections | |
| AR047581A1 (es) | Vacunas de calicivirus felino | |
| RU2021112503A (ru) | Поливалентная вакцина против м. hyo и её применение | |
| ATE310008T1 (de) | Immunologische adjuvans verbindungen | |
| DK2569007T3 (en) | VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies | |
| AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
| WO2006046017A8 (en) | Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter | |
| ATE495758T1 (de) | Virulentes systemisches felines calicivirus | |
| Frank et al. | The probability of severe disease in zoonotic and commensal infections | |
| AR019785A1 (es) | Pestivirus no diseminantes | |
| RU2002115519A (ru) | Способ вакцинопрофилактики эпидемического паротита на крайнем севере | |
| AU2003294192A8 (en) | Inclusion bodies as antigens for the oral vaccination of animals | |
| WO2004043286A3 (en) | Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen | |
| ATE540693T1 (de) | Impfung und impfstoffe gegen hundeherpesvirus | |
| Ford | Kennel cough revisited | |
| AB et al. | Dramatic Improvement in the Efficacy of Foot and Mouth Disease Vaccines by Co-administration of Echinacea | |
| Nahed IMM et al. | Immune response chicken vaccinated with combined E. coli and multocida vaccine private |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |